The Global Spinal Muscular Atrophy Market Continues To Grow Owing To the Newly Launched FDA Approved Products in the Market and Easier Government Reimbursement Policies across the Globe
Spinal muscular atrophy, also known as SMA, is a progressive condition wherein nerve fibers in the spinal cord are replaced by scar tissues. This degeneration occurs predominantly in the long muscle fibers and involves the progressive weakening and eventually the complete loss of muscle function. This condition can result from a variety of pathological conditions, including traumatic injuries, strokes, age-related macular degeneration, and spinal cord injuries. It can also be the result of various hormonal changes, such as during puberty and pregnancy or the body's response to disease or injury. Spinal muscular atrophy can have several different potential causes, including genetic factors, exposure to disease and/or injury, abnormalities in the spine, as well as the progressive weakening of muscles at the point of its attachment to the spinal cord. Market Dynamics The factors driving the global growth of the spinal muscular atrophy market include an increase in the cases of ...